Buffett's Secret Strategies: Applying His Wisdom in India

ELI5/TLDR

Gautam Baid — author of The Joys of Compounding, an India-focused fund manager in the US who once applied to 1,300 stock-market jobs from the graveyard shift of a San Francisco hotel — walks through how he actually picks stocks in India. The thesis: India is unusually rich hunting ground (one in five large companies became a 10-bagger over the past decade), so an active picker willing to do the grunt work can win. His method is two-part — own a core of long-term compounders, and run a smaller tactical book of “special situations” (spin-offs, mergers, promoter changes) where a temporary mispricing hands you a cheap, good business. Underneath it all is the older, duller lesson: the big money is made by buying quality during bear markets and then sitting still.

The Full Story

Compounding is the whole worldview, not a formula

Baid’s book takes its name from the idea that the most powerful force in finance — interest earning interest — applies to far more than money. Knowledge compounds. Goodwill compounds. The subtitle is “the passionate pursuit of lifelong learning,” and he means it literally: he treats reading and thinking as the asset that throws off the highest long-run return.

“Value investing is not just about stocks and business fundamentals. It’s something much more deeper. It’s more about living a life which is aligned with your value system.”

The practical edge of this, for investing, is patience. Compounding only works if you leave it alone, and leaving it alone is hard. His trick for staying calm: for any business, only two or three variables actually drive the returns. Track those, and the daily noise stops mattering.

“You have to separate the long-term signal from the short-term noise. And you do that by embracing inactivity.”

The origin story does real work here

The biography isn’t filler — it’s the proof-of-concept for his own argument. Baid started like everyone does, badly: he bought a steel stock and a power-sector fund in 2007–08 purely because they were hot and rising, ignored valuation, and watched both fall 70–80%. He calls this paying “tuition fees,” and names the two biases that got him — recency (assuming recent trends continue forever) and vividness (a dramatic chart or headline hijacking your attention).

Then the harder chapter. He moved to the US in 2015 with no job, got rejected from his first three stock-market interviews, ran out of money, and refused to sell a single Indian share to cover rent — because selling would interrupt compounding. So he worked the 11pm–7am hotel desk for 15 months, using the dead hours to read every value-investing blog he could find and to fire off job applications.

“Over those 15 months I’d applied to more than 1300 stock market jobs… To be rejected more than 1300 times and still keep on going is only possible if you’re truly fiercely committed.”

One LinkedIn quick-apply later, he landed a portfolio-manager role outright — skipping the junior-analyst ladder he’d expected to climb. His read on why: the 15 months of reading had quietly built the foundation. The payoff arrives all at once, late.

“The power of compounding is backloaded… Many of life’s big failures are people who did not realize how close they were to success when they gave up.”

Why India, and why now

After years tracking global markets with a US emphasis, India stood out to him for sheer breadth of opportunity. The statistic he keeps returning to: in the last decade, 103 of the BSE 500 companies became 10-baggers — one in five delivered roughly 1,000%. No other market comes close, which is exactly why active picking can pay off there in a way it largely can’t in the US, where seven stocks drive most of the index.

He layers a macro argument on top. As of end-2024 the US was 25% of global GDP but 67% of global market cap — two of every three invested dollars sat in one country. As that concentration unwinds and the dollar weakens, capital diversifies outward, and a high-growth non-aligned country like India stands to catch a meaningful slice. He’s careful, though, not to drink the local Kool-Aid: the two big risks he flags for foreign allocators are geopolitical (a near-war with a neighbour this year) and political stability (a fragmented coalition government would slow reform and de-rate Indian valuations).

The three old principles, restated

Nothing new here, and Baid doesn’t pretend otherwise — these are Ben Graham’s, and they’re load-bearing:

A stock is part-ownership of a business, not a ticker. So you look at the balance sheet, cash flow, working capital, and the people.
Mr. Market is manic-depressive. Markets are efficient most of the time, not all of the time — and the gap between those two claims is where the money lives. Wait for his fearful days.
Margin of safety. A great business at the wrong price is not a great stock.

His illustration: Rajratan Global Wire, a microcap making bead wire for tyres, available in 2020 at a P/E of 5 on depressed (not peak) earnings, because nobody wanted anything auto-related. When the cycle turned, it became a 20-bagger in two years. The general law he draws from it:

“The really big multibaggers you find only after a bear market.”

The actual machinery: variant perception + structural trends

This is the most useful part of the conversation — Baid’s portfolio is built on two pillars.

Long-term structural trends (70–80% of the book). Industries with favourable structure — monopoly, duopoly, oligopoly — with predictable cash flows and an industry tailwind. He likes “value migration”: India’s 30-year shift from public to private, unorganised to organised. Current examples he names: financialisation of savings, branded discretionary consumption, AI-adjacent power and data centres, GLP-1 weight-loss drugs, defence, gold financiers.

Variant perception (20–30%, the tactical alpha). A differentiated view on a business’s near-term trajectory — usually where ROCE (return on capital employed) is about to expand, which drives a valuation re-rating. He rattles off eight catalysts, the cleaner ones being: a product-mix shift into higher-margin categories; operating leverage from unused capacity at the start of an upcycle; deleveraging (less debt mechanically lifts both profit and ROCE); and corporate actions like de-mergers and merger arbitrage. He prefers improving asset turns over improving margins, because high margins attract competition.

The special-situations case studies make it concrete:

Aarti Pharma Labs (2023 de-merger): spun out of Aarti Industries; forced selling (midcap funds couldn’t hold a small-cap, chemical funds couldn’t hold a pharma name) crushed it to a P/E of 12 while a lower-quality sister company traded at 22. He made it his largest position at 8%; up 250%+ in two years.
Equitas (2022 merger arbitrage): a 15% arbitrage spread, a banking tailwind, and the underlying bank cheap at 1.5x book — three sources of upside stacked.
CG Power (promoter change): the Murugappa group took over a good-but-mismanaged asset at ₹12–13; the stock went up 50x. His rule for promoter-change bets: the magic comes from a good asset being badly run, where a competent new owner unlocks the gap. “Investing is all about delta — the rate of change.”

And the counter-example he volunteers: India Bulls Real Estate / Embassy, where the merger took far longer than expected. Hence: diversify across special situations, know the base rates, and prefer promoter-group takeovers (long horizon) over private equity (flip-and-sell).

Selling, sizing, and the defence debate

He sells on three triggers: obnoxious valuation (P/E north of 100, where the future is already priced in), a corporate-governance or capital-misallocation red flag, or finding a clearly superior opportunity. On sizing, he opens positions at 3–5%, occasionally 10% for exceptional setups, holds 5–10% cash for bear-market buying power, and trims any position that grows to a “discomfortingly large” size — what he calls selling down to his “sleeping point.”

On the crowded defence trade, he refuses the lazy “it’s already run” objection. His framing: every 100-bagger first became a 10x and then ran another 10x; winners look expensive precisely because they hit highs right after corrections. Don’t fight a government-backed mega-trend, and watch out for anchoring bias — refusing to buy at today’s price because you remember a lower one. The discipline isn’t cheapness; it’s the “justified P/E,” which he says is set by the interplay of ROCE and growth (he points to two white papers for the method). As long as a company grows fast, valuations don’t de-rate — they go from reasonable to expensive to absurd. The danger is a sudden growth slowdown, which de-rates violently and causes permanent loss.

What he avoids, and why boring wins

Bottom-up always. Even within a hot theme like defence, plenty of names have huge order books and patchy execution. He steers clear of deep cyclicals and commodities (metals look cheapest exactly at peak earnings — the worst moment to buy), heavily regulated sectors with no pricing power (sugar, tea), capital guzzlers, and illiquid micro-caps with no track record. The throughline:

“Investing is a negative art. Knowing what not to do is far far more important than knowing what to do.”

He’s wary of frenzy as a signal in itself — frenzy means capital flooding in, which means rising competition and falling returns on capital. He’d rather go where capital is leaving and the industry is consolidating. He applies the same lens to AI: buy the picks-and-shovels (power ancillaries, transmission and distribution, water treatment for data centres) rather than the glamorous application layer that will get commoditised. And he’s blunt about the unlisted/pre-IPO frenzy — HDB Financial’s IPO band sat ~70% below its grey-market price, which tells you what private-market pricing is worth.

Idea sourcing and the life lessons

His edge is mostly grind: he reads every BSE filing daily — M&A, JVs, expansion announcements — plus investor presentations, annual reports, concall transcripts, DRHPs, initiating-coverage reports, the top holdings of PMS managers he respects (free on PMS Bazaar), Screener.in, and forums like ValuePickr. The point isn’t to act daily — it’s to keep a live watchlist of 10–15 high-potential names ready, so when something goes wrong with a holding he has somewhere to recycle the capital.

The conversation closes on the softer compounding. The book’s real message is that the best investment is in yourself — intellectual and social capital compound like money does. He keeps a daily gratitude journal (three things he’s grateful for, what would make today great, two affirmations; at night, three good things and two things learned). And he tells two “good karma” stories — quietly boosting a smaller writer on Twitter, and self-publishing his book at zero royalty just to help people — both of which circled back years later to land him the Columbia Business School deal and, eventually, Buffett’s written praise.

Key Takeaways

India’s breadth is the edge. 103 of the BSE 500 became 10-baggers in a decade; one in five large companies returned ~1,000%. Active picking can pay off in India in a way it can’t in a seven-stock US index.
Two-pillar portfolio: 70–80% long-term structural compounders (favourable industry structure + tailwind + value migration), 20–30% tactical “variant perception” bets for alpha.
Variant perception = a near-term ROCE expansion the market hasn’t priced. Catalysts: margin-mix shift, operating leverage, deleveraging, de-mergers, merger arbitrage, better asset turns, working-capital improvement. Prefer rising asset turns over rising margins (margins attract competition).
Special situations are where forced selling hands you a cheap good business — index-mandate dumping after a spin-off (Aarti Pharma), stacked merger-arb spreads (Equitas), good-asset-badly-run promoter changes (CG Power, 50x). The multibagger comes from a bad-run asset, not a well-run one.
The big multibaggers come after bear markets, when quality is on sale. Normal markets give you compounders; bear markets give you the 20-baggers.
Three sell triggers: absurd valuation (P/E >100), governance/capital-misallocation red flag, or a clearly better opportunity.
Sizing: open at 3–5% (up to 10% for exceptional setups), hold 5–10% cash, trim to your “sleeping point.” Allocation, not stock selection, is what made the great investors rich.
“Justified P/E” is set by ROCE × growth. A fast-grower’s valuation won’t de-rate while growth holds — the killer is a sudden growth slowdown, which de-rates violently. Beware anchoring to a stock’s old low price.
Avoid: deep cyclicals and commodities (cheapest at peak earnings), heavily regulated low-pricing-power sectors (sugar, tea), capital guzzlers, illiquid no-track-record micro-caps. Frenzy itself is a sell signal — it means rising competition and falling returns on capital.
Play AI via picks-and-shovels (power T&D, data-centre water treatment), not the commoditising application layer.
The edge is grind: read every BSE filing daily to keep a live 10–15 name watchlist for recycling capital, not to trade.
Compounding applies beyond money — knowledge, relationships, and goodwill compound too; the payoff is backloaded, so don’t quit early.

Claude’s Take

This is a clean, generous distillation of a coherent practitioner. Baid isn’t selling a secret — despite the clickbait title, there’s almost no “Buffett’s secret” here, just well-organised orthodoxy delivered with unusually concrete India examples. The value is in the specificity: the variant-perception catalogue, the three named special-situation case studies with actual P/Es, and the “good-asset-badly-run” rule for promoter changes are the kind of detail you rarely get from an interview, where guests usually hide behind aphorisms.

The honest caveats. First, survivorship and hindsight saturate the whole thing — every case study is a win (Rajratan 20x, Aarti 250%, CG Power 50x), narrated after the fact, by a man whose job is partly to market a fund. The India Bulls counter-example is the only loss he volunteers, and even that’s framed as a lesson rather than a wound. Second, the “103 became 10-baggers” stat is real but selective: a decade measured from a post-GFC base will flatter any market, and it says nothing about the survivorship-adjusted return of someone actually trying to pick them in advance. Third, the defence/AI bullishness is genuinely contrarian-sounding but also conveniently long whatever’s already run, with “don’t fight the government” doing a lot of justifying work.

What survives the skepticism is the discipline scaffolding — sell triggers, position sizing to a sleeping point, the watchlist-as-recycling-buffer, the negative-art framing of avoidance. That’s transferable and unglamorous, which is the tell that it’s probably real. The biography is inspiring and almost certainly slightly polished, but 1,300 applications is a specific enough number to believe.

A 7: dense, concrete, well-structured, and honest about risk in places — but it’s a generous restatement of known principles rather than new insight, and the marketing gravity is always present. Worth the read for the special-situations machinery; discount the war stories by the usual hindsight factor.